Yarrow Bioscience, Inc. (YARW) Insider Trading & SEC Filings
Last SEC filing
Yarrow Bioscience, Inc. (YARW) has filed 12 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-30. 13 Form 8-K material event filings were reported by YARW in the last 90 days. InsiderAlpha tracks every YARW SEC filing - Form 4, Form 144, and 8-K - in real time, including Rule 10b5-1 plan detection.
About Yarrow Bioscience, Inc. (YARW)
Yarrow Bioscience, Inc. trades under the ticker YARW. InsiderAlpha tracks 35 primary SEC Form 4 filings from 12 reporting insiders for YARW since 2024, sourced directly from SEC EDGAR.
| Sector | Health Care insider trading |
|---|---|
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
| SEC CIK | 0001566044 |
90-Day SEC Filing Activity
| Form 4 filings (90d) | 12 |
|---|---|
| Form 8-K filings (90d) | 13 |
| Latest Form 4 filing | 2026-07-30 |
Recent YARW Insider Transactions (Form 4)
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| RTW Fund Group GP, LLC | 10% Owner | J - Other acquisition / disposition | 133.3K | $0.00 | - | SEC | |
| David Domzalski | PRESIDENT AND CEO | F - Tax withholding / forfeiture | 79.4K | $0.90 | $71K | SEC | |
| Tyler Zeronda | CHIEF FINANCIAL OFFICER | F - Tax withholding / forfeiture | 22.5K | $0.90 | $20K | SEC | |
| Iain Stuart | CHIEF SCIENTIFIC OFFICER | F - Tax withholding / forfeiture | 15.4K | $0.90 | $14K | SEC | |
| Mutya Harsch | CHIEF LEGAL OFFICER AND GC | F - Tax withholding / forfeiture | 22.5K | $0.90 | $20K | SEC | |
| David Domzalski | PRESIDENT AND CEO | F - Tax withholding / forfeiture | 12.2K | $0.65 | $8K | SEC | |
| Mutya Harsch | CHIEF LEGAL OFFICER AND GC | F - Tax withholding / forfeiture | 3.5K | $0.65 | $2K | SEC | |
| Iain Stuart | CHIEF SCIENTIFIC OFFICER | F - Tax withholding / forfeiture | 2.4K | $0.65 | $2K | SEC | |
| Tyler Zeronda | CHIEF FINANCIAL OFFICER | F - Tax withholding / forfeiture | 3.5K | $0.65 | $2K | SEC | |
| David Domzalski | PRESIDENT AND CEO | A - Grant or award | 30.8K | $0.31 | $10K | SEC | |
| Iain Stuart | CHIEF SCIENTIFIC OFFICER | F - Tax withholding / forfeiture | 2.9K | $0.60 | $2K | SEC | |
| David Domzalski | PRESIDENT AND CEO | F - Tax withholding / forfeiture | 14.2K | $0.60 | $9K | SEC | |
| Mutya Harsch | CHIEF LEGAL OFFICER AND GC | F - Tax withholding / forfeiture | 4.0K | $0.60 | $2K | SEC | |
| Tyler Zeronda | CHIEF FINANCIAL OFFICER | F - Tax withholding / forfeiture | 4.0K | $0.60 | $2K | SEC | |
| Tyler Zeronda | CHIEF FINANCIAL OFFICER | F - Tax withholding / forfeiture | 3.4K | $0.34 | $1K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Yarrow Bioscience, Inc. (YARW). Updated in real time as new filings are submitted to the SEC.
Most-Active YARW Insiders - Last 90 Days
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| David Domzalski | 3 | $89K |
| Tyler Zeronda | 3 | $22K |
| Iain Stuart | 2 | $15K |
| Mutya Harsch | 2 | $22K |
| RTW Fund Group GP, LLC | 2 | - |
Recent YARW Form 8-K Material Events
- - Item 8.01 [SEC]
- - Item 1.01, 2.01, 2.02, 3.02, 3.03, 5.01, 5.02, 5.03, 5.05, 7.01, 9.01 [SEC]
- - Other · neutral [SEC]
Trading halt (T3) for VYNE. VYNE - - Other · neutral [SEC]
Trading halt (T1) for VYNE. VYNE - - Other · neutral [SEC]
Trading halt (T1) for VYNE. VYNE
Recent Insider Filings
- - RTW Fund Group GP, LLC (10% Owner)
- - Mona Ashiya (Director)
- - Tyler Zeronda (Director)
- - Tyler Zeronda (CHIEF FINANCIAL OFFICER)
- - Iain Stuart (CHIEF SCIENTIFIC OFFICER)
Form 4 Transaction Code Reference
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in YARW insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
YARW Insider Trading - FAQ
- What is the latest insider trade for YARW?
- Yarrow Bioscience, Inc. (YARW) had 12 insider filings in the last 90 days, with the most recent on 2026-07-30. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
- How many insiders are buying YARW stock?
- 0 insider purchases of YARW were filed in the last 90 days.
- How many insiders are selling YARW stock?
- 0 insider sales of YARW were filed in the last 90 days.
- Where can I see YARW SEC filings (Form 4, 10-K, 10-Q, 8-K)?
- This page tracks YARW Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care Companies with Insider Activity
Other companies in the InsiderAlpha index with a significant SEC Form 4 insider-trading footprint:
- $ZBIO Zenas BioPharma, Inc.
- $ZURA Zura Bio Ltd
- $ZYME Zymeworks Inc.
- $ABP Abpro Holdings, Inc.
- $AEMD AETHLON MEDICAL INC
- $AHCO AdaptHealth Corp.
- $AIM AIM ImmunoTech Inc.
- $AKTX Akari Therapeutics Plc
- $ALMS ALUMIS INC.
- $ANNX Annexon, Inc.
Related Companies - Recent Insider Activity
- UNITED THERAPEUTICS Corp (UTHR)
- Liquidia Corp (LQDA)
- BeOne Medicines Ltd. (ONC)
- PERRIGO Co plc (PRGO)
- Processa Pharmaceuticals, Inc. (PCSA)
- Nuvalent, Inc. (NUVL)
- CYTOKINETICS INC (CYTK)
- Elanco Animal Health Inc (ELAN)
- Avalo Therapeutics, Inc. (AVTX)
- NATURES SUNSHINE PRODUCTS INC (NATR)
Learn More
- What is SEC Form 4?
- How to read insider buying signals
- Rule 10b5-1 trading plans explained
- The cluster buying signal
Open the live YARW dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.